$TTMI earnings report

TTM reported record third-quarter net sales of $1.2 billion, up 60% year on year, with adjusted EBITDA margin reaching 20.1% and fourth-quarter net-sales guidance of $1.42 billion to $1.44 billion. AlphAI read TTM Technologies's Third Quarter 2026 filing as strong. 2 quarters are on record below.

Third Quarter 2026

AlphAI · Earnings readTTMI · Third Quarter 2026 · ended September 28, 2026

TTM reported record third-quarter net sales of $1.2 billion, up 60% year on year, with adjusted EBITDA margin reaching 20.1% and fourth-quarter net-sales guidance of $1.42 billion to $1.44 billion.

✓Strong quarter

Record sales, non-GAAP EPS and adjusted EBITDA were accompanied by year-over-year expansion in gross, operating and adjusted EBITDA margins, strong operating cash flow, a 2.13 total book-to-bill ratio and guidance that calls for higher fourth-quarter sales.

Revenue
$1.20B
up 60% year on year y/y
Aerospace & Defense operating segment
$417M
up 21% y/y
Gross margin · GAAP
24.2 %
EPS · non-GAAP
$ 1.46
Fourth quarter of 2026; full year 2026; preliminary full year 2027 outlook
Fourth quarter of 2026 net sales: $1.42 billion to $1.44 billion; full year 2026 expected net sales: $4.47 billion to $4.49 billion; preliminary 2027 full year expected net sales: $6.5 billion to $6.75 billion

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Third Quarter 2026 net salesGAAP$1.20B–up 60% year on year
Third Quarter 2026 cost of goods soldGAAP912.0M––
Third Quarter 2026 gross profitGAAP$291.9M––
Third Quarter 2026 gross marginGAAP24.2 %––
Third Quarter 2026 selling and marketing expenseGAAP25.14M––
Third Quarter 2026 general and administrative expenseGAAP87.55M––
Third Quarter 2026 research and development expenseGAAP9.65M––
Third Quarter 2026 amortization of definite-lived intangiblesGAAP6.89M––
Third Quarter 2026 restructuring chargesGAAP380K––
Third Quarter 2026 total operating expensesGAAP129.6M––
Third Quarter 2026 operating incomeGAAP$162.3M––
Third Quarter 2026 operating marginGAAP13.5 %––
Third Quarter 2026 interest expenseGAAP−12.81M––
Third Quarter 2026 realized and unrealized losses on derivative instrumentsGAAP−6.10M––
Third Quarter 2026 other, netGAAP−1.64M––
Third Quarter 2026 income before income taxesGAAP141.7M––
Third Quarter 2026 income tax provisionGAAP−56.90M––
Third Quarter 2026 net incomeGAAP$84.80M––
Third Quarter 2026 basic earnings per shareGAAP$ 0.80––
Third Quarter 2026 diluted earnings per shareGAAP0.79––
Third Quarter 2026 non-GAAP gross profitnon-GAAP$299.0M––
Third Quarter 2026 non-GAAP gross marginnon-GAAP24.8 %––
Third Quarter 2026 non-GAAP operating incomenon-GAAP$209.0M––
Third Quarter 2026 non-GAAP operating marginnon-GAAP17.4 %––
Third Quarter 2026 non-GAAP net incomenon-GAAP$157.8M––
Third Quarter 2026 non-GAAP earnings per diluted sharenon-GAAP$ 1.46––
Third Quarter 2026 adjusted EBITDAnon-GAAP$242.3M––
Third Quarter 2026 adjusted EBITDA marginnon-GAAP20.1 %––
Third Quarter 2026 operating cash flowother$154.7M––
Third Quarter 2026 capital expenditures, netother−79.92M––
Third Quarter 2026 free cash flowother$74.79M––
First Three Quarters 2026 net salesGAAP$3.05B––
First Three Quarters 2026 gross profitGAAP$684.9M––
First Three Quarters 2026 gross marginGAAP22.4 %––
First Three Quarters 2026 operating incomeGAAP$343.8M––
First Three Quarters 2026 operating marginGAAP11.3 %––
First Three Quarters 2026 net incomeGAAP$217.8M––
First Three Quarters 2026 diluted earnings per shareGAAP2.03––
First Three Quarters 2026 non-GAAP net incomenon-GAAP$344.7M––
First Three Quarters 2026 non-GAAP earnings per diluted sharenon-GAAP$ 3.21––
First Three Quarters 2026 adjusted EBITDAnon-GAAP$542.0M––
First Three Quarters 2026 adjusted EBITDA marginnon-GAAP17.7 %––
First Three Quarters 2026 operating cash flowother$272.9M––
First Three Quarters 2026 capital expenditures, netother−237.1M––
First Three Quarters 2026 free cash flowother$35.74M––
Cash and cash equivalents as of September 28, 2026GAAP$876.3M––
Short-term debt, including current portion of long-term debt, as of September 28, 2026GAAP$184M––
Long-term debt, net of discount and issuance costs, as of September 28, 2026GAAP$1.46B––
Total stockholders’ equity as of September 28, 2026GAAP$2.04B––
Total book to billother2.13––
Total A&D program backlogother$2B––
Net leverage ratio as of September 30, 2026non-GAAP2.8x of pro-forma adjusted TTM EBITDA––

Segments

SegmentRevenueq/qy/y
Aerospace & Defense operating segmentAerospace & Defense was 34 % of total net sales.$416.5M–up 21%
Commercial operating segmentCommercial segment operating income was 166,279 (In thousands).$787.9M––
Data Center and Networking end marketDriven by continued AI demand.41 % of total net sales–up 115%
Medical, Industrial, and Instrumentation end marketManagement cited this market as a contributor to year-on-year growth.18 % of total net sales–up 97%
Automotive end marketEnd-market mix declined from 11 % in the third quarter of 2025.7 % of total net sales––

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Fourth quarter of 2026; full year 2026; preliminary full year 2027 outlook

  • RevenueFourth quarter of 2026 net sales: $1.42 billion to $1.44 billion; full year 2026 expected net sales: $4.47 billion to $4.49 billion; preliminary 2027 full year expected net sales: $6.5 billion to $6.75 billion
  • NoteFourth quarter of 2026 non-GAAP net income: $1.77 to $1.83 per diluted share
  • NoteFull year 2026 expected non-GAAP net income: $4.97 to $5.03 per diluted share
  • NotePreliminary 2027 full year expected non-GAAP net income: $8.10 to $8.90 per diluted share
  • NoteFourth quarter estimate and full year 2026 outlook include contributions from closed STG and Epiq acquisitions and associated financing costs.
  • NoteInitial 2027 full year forecast includes contributions from recently closed acquisitions and associated financing costs while excluding impacts of planned or potential acquisitions that have not been closed.

What drove it

  • Net sales were an all-time quarterly record of $1.2 billion, with all key markets contributing to 60% year-on-year growth.
  • Data Center and Networking represented 41 % of third-quarter net sales and was driven by continued AI demand.
  • Aerospace and Defense represented 34 % of third-quarter net sales, and total A&D program backlog was $2.0 billion.
  • Adjusted EBITDA margin reached 20.1 %, exceeding 20 % for the first time, according to management.
  • Closed acquisitions of STG and Epiq are included in current guidance.

Concerns

  • The release characterizes the financial results as preliminary; actual results disclosed in the Form 10-Q may differ following financial closing procedures, final adjustments and review by the independent registered accounting firm.
  • Third-quarter realized and unrealized losses on derivative instruments were (6,103 ) (In thousands).
  • The proposed Ophir Optics acquisition is an all-cash $650 million transaction and is expected to be funded with cash on hand, expected future cash flow and revolving-credit-facility borrowings.
  • Planned acquisitions of Ophir Optics, Merlin Circuit Technology Ltd., Merlin Flex Ltd. and ILFA GmbH are excluded from current guidance.
  • Management cannot provide a reconciliation of forward non-GAAP net income per diluted share to GAAP net income per diluted share without unreasonable effort.

What to watch

  • Fourth-quarter net sales delivery against the guided range of $1.42 billion to $1.44 billion.
  • Whether adjusted EBITDA margin sustains the third-quarter record of 20.1 %.
  • Data Center and Networking demand, which management said was driven by continued AI demand.
  • Aerospace and Defense backlog conversion from the reported $2.0 billion total A&D program backlog.
  • Closing and financing of the Ophir Optics, Merlin and ILFA transactions, which are excluded from current guidance.
  • Leverage progress toward management’s targeted range of 1.5-2.0x.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 876,347 (In thousands) as of September 28, 2026, compared to $ 501,234 (In thousands) as of December 29, 2025.
  • Accounts receivable, net were 836,362 (In thousands), contract assets were 793,552 (In thousands), and inventories were 325,432 (In thousands) as of September 28, 2026.
  • Short-term debt, including current portion of long-term debt, was $ 184,000 (In thousands), and long-term debt, net of discount and issuance costs, was $ 1,459,872 (In thousands) as of September 28, 2026.
  • Third-quarter operating cash flow was $ 154,711 (In thousands), capital expenditures, net were (79,921 ) (In thousands), and free cash flow was $ 74,790 (In thousands).
  • Following the Epiq Solutions acquisition, management stated net leverage as of September 30, 2026 was 2.8x of pro-forma adjusted TTM EBITDA. Management expects leverage to be within its targeted range of 1.5-2.0x by the expected closing date of the proposed Ophir Optics acquisition.

Analysis

TTM reported a record third quarter, with net sales of $1.2 billion, up 60% year on year from $752.7 million. GAAP operating income was $162.3 million versus $71.9 million, and GAAP net income was $84.8 million, or $0.79 per diluted share, versus $53.1 million, or $0.50 per diluted share. Non-GAAP net income reached $157.8 million, or $1.46 per diluted share, compared with $71.0 million, or $0.67 per diluted share.

Profitability expanded alongside revenue. GAAP gross margin was 24.2% versus 20.8%, GAAP operating margin was 13.5% versus 9.6%, and adjusted EBITDA margin was 20.1% versus 16.1%. Adjusted EBITDA was a record $242.3 million. The release attributes demand strength to all key markets, particularly Data Center and Networking, which represented 41% of sales and was driven by continued AI demand, while Aerospace and Defense represented 34% of sales and had $2.0 billion of program backlog.

Cash generation remained positive, with operating cash flow of $154.7 million and free cash flow of $74.8 million in the quarter. Cash and cash equivalents were $876.3 million as of September 28, 2026. Debt was $184.0 million of short-term debt and $1.46 billion of long-term debt, net of discount and issuance costs. Management said pro-forma net leverage was 2.8x adjusted TTM EBITDA following the Epiq acquisition and expects leverage to be within 1.5-2.0x by the expected closing of the Ophir Optics transaction.

The fourth-quarter outlook calls for net sales of $1.42 billion to $1.44 billion and non-GAAP net income of $1.77 to $1.83 per diluted share. Full-year 2026 guidance calls for $4.47 billion to $4.49 billion of net sales and $4.97 to $5.03 per diluted share of non-GAAP net income. The company also initiated preliminary 2027 guidance for $6.5 billion to $6.75 billion of net sales and $8.10 to $8.90 per diluted share of non-GAAP net income. Current guidance includes STG and Epiq, but excludes the proposed Ophir, Merlin and ILFA transactions.

Management, verbatim

“Once again, we delivered quarterly records for both net sales and non-GAAP EPS,”

Edwin Roks, CEO of TTM

“All key markets contributed to our 60% year on year growth with Data Center & Networking up 115%, Medical, Industrial & Instrumentation up 97%, and Aerospace & Defense up 21%.”

Edwin Roks, CEO of TTM

“Our margin expansion efforts are producing results as evidenced by adjusted EBITDA margin exceeding 20% for the first time.”

Edwin Roks, CEO of TTM

Not in the filing

stated, not guessed
  • Prior-quarter comparisons for reported income-statement metrics were not provided.
  • Dividend and share-repurchase activity were not reported.
  • GAAP forward guidance was not provided.
  • Forward gross-margin, operating-expense and tax-rate guidance were not provided.
  • Individual end-market revenue dollars were not provided; the release provided end-market mix percentages.
  • Prior outlook was not provided, so no comparison of actual results with prior guidance is available.

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Second quarter of 2026

AlphAI · Earnings readTTMI · Second quarter of 2026 · ended June 29, 2026

TTM Technologies, Inc. reported record second-quarter net sales of $1.0 billion and record non-GAAP net income per diluted share of $0.99, supported by Data Center and Networking demand.

✓Strong quarter

Net sales rose 37% year on year to an all-time quarterly record, GAAP operating income and net income increased from the prior-year quarter, adjusted EBITDA margin improved to 16.6%, and third-quarter and full-year outlook calls for further growth.

Revenue
$1B
up 37% year on year y/y
Data Center and Networking end market
40% of total net sales
increased 91% year on year y/y
Gross margin · GAAP
21.1%
EPS · non-GAAP
$0.99
Third quarter of 2026 and full year 2026 outlook
Third quarter of 2026: $1.10 billion to $1.14 billion; full year 2026: approximately $4.4 billion

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net sales, second quarter 2026GAAP$1B–up 37% year on year
Cost of goods sold, second quarter 2026GAAP792.2M––
Gross profit, second quarter 2026GAAP211.9M––
Gross margin, second quarter 2026GAAP21.1%––
Selling and marketing expense, second quarter 2026GAAP25.49M––
General and administrative expense, second quarter 2026GAAP62.11M––
Research and development expense, second quarter 2026GAAP7.98M––
Amortization of definite-lived intangibles, second quarter 2026GAAP6.89M––
Restructuring charges, second quarter 2026GAAP340K––
Total operating expenses, second quarter 2026GAAP102.8M––
Operating income, second quarter 2026GAAP$109.1M––
Operating margin, second quarter 2026GAAP10.9%––
Interest expense, second quarter 2026GAAP−10.50M––
Loss on extinguishment of debt, second quarter 2026GAAP−747K––
Unrealized loss on derivative instruments, second quarter 2026GAAP−13.99M––
Other, net, second quarter 2026GAAP−2.57M––
Income before income taxes, second quarter 2026GAAP81.25M––
Income tax benefit (provision), second quarter 2026GAAP1.8M––
Net income, second quarter 2026GAAP$83M––
Basic earnings per share, second quarter 2026GAAP$0.80––
Diluted earnings per share, second quarter 2026GAAP$0.77 per diluted share––
Adjusted EBITDA, second quarter 2026non-GAAP$166.8M––
Adjusted EBITDA margin, second quarter 2026non-GAAP16.6% of net sales––
Non-GAAP net income, second quarter 2026non-GAAP$106.9M––
Non-GAAP earnings per diluted share, second quarter 2026non-GAAP$0.99 per diluted share––
Cash flow from operations, second quarter 2026GAAP$96.4M––
Cash flow from operations as a percentage of net sales, second quarter 2026GAAP9.6% of net sales––
Total book to bill, second quarter 2026other1.49––
Net leverage ratio, second quarter 2026other0.9x––
Net sales, first two quarters 2026GAAP1.85B––
Gross profit, first two quarters 2026GAAP393.0M––
Gross margin, first two quarters 2026GAAP21.2%––
Total operating expenses, first two quarters 2026GAAP211.5M––
Operating income, first two quarters 2026GAAP181.5M––
Operating margin, first two quarters 2026GAAP9.8%––
Net income, first two quarters 2026GAAP133.0M––
Basic earnings per share, first two quarters 2026GAAP$1.28––
Diluted earnings per share, first two quarters 2026GAAP$1.24––

Segments

SegmentRevenueq/qy/y
Data Center and Networking end marketcontinued AI demand40% of total net sales–increased 91% year on year
Aerospace and Defense end markethealthy improvement in backlog, reflecting positive alignment with projected priority defense programs37% of total net sales–14% year on year revenue growth
Medical, Industrial and Instrumentation end marketNot reportedNot reported–33% year on year revenue growth

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Third quarter of 2026 and full year 2026 outlook

  • RevenueThird quarter of 2026: $1.10 billion to $1.14 billion; full year 2026: approximately $4.4 billion
  • NoteThird quarter of 2026 non-GAAP net income: $1.21 to $1.27 per diluted share
  • NoteFull year 2026 non-GAAP net income per share: approach $5.00
  • NoteThird quarter estimate and full year outlook do not include any contribution or impact from pending acquisitions.

What drove it

  • Net sales grew 37% year on year, powered largely by ongoing robust demand in the Data Center and Networking end market.
  • Data Center and Networking represented 40% of total net sales and increased 91% year on year.
  • Medical, Industrial and Instrumentation revenue grew 33% year on year.
  • Aerospace and Defense represented 37% of total net sales, grew 14% year on year, and had a healthy improvement in backlog.
  • Total book to bill was 1.49, and total program backlog was over $1.7 billion.
  • Gross margin was 21.1%, operating margin was 10.9%, and adjusted EBITDA margin was 16.6% of net sales.

Concerns

  • The second quarter included an unrealized loss on derivative instruments of 13,994 (In thousands).
  • The second quarter included a loss on extinguishment of debt of 747 (In thousands).
  • Third-quarter and full-year outlook exclude any contribution or impact from pending acquisitions.
  • The company stated that future non-GAAP earnings per diluted share exclude restructuring actions, impairment charges, unusual gains and losses including but not limited to unrealized foreign exchange translation, and tax adjustments.

What to watch

  • Third-quarter net sales outlook of $1.10 billion to $1.14 billion.
  • Third-quarter non-GAAP net income outlook of $1.21 to $1.27 per diluted share.
  • Full-year 2026 net sales expectation of approximately $4.4 billion and non-GAAP net income per share expected to approach $5.00.
  • Continued Data Center and Networking demand and the pace of AI-related demand.
  • Aerospace and Defense backlog and projected priority defense programs.
  • Expected third-quarter 2026 closing of the Swiss Technology Group AG and ILFA GmbH acquisitions.

Balance sheet and cash flow

  • Cash and cash equivalents: $507,905 (In thousands) as of June 29, 2026; $501,234 (In thousands) as of December 29, 2025.
  • Accounts receivable, net: 720,143 (In thousands) as of June 29, 2026; 563,741 (In thousands) as of December 29, 2025.
  • Contract assets: 596,036 (In thousands) as of June 29, 2026; 468,006 (In thousands) as of December 29, 2025.
  • Inventories: 307,972 (In thousands) as of June 29, 2026; 250,057 (In thousands) as of December 29, 2025.
  • Total current assets: 2,249,899 (In thousands) as of June 29, 2026; 1,855,406 (In thousands) as of December 29, 2025.
  • Property, plant and equipment, net: 1,187,809 (In thousands) as of June 29, 2026; 1,010,710 (In thousands) as of December 29, 2025.
  • Total assets: 4,415,709 (In thousands) as of June 29, 2026; 3,840,331 (In thousands) as of December 29, 2025.
  • Short-term debt, including current portion of long-term debt: $4,000 (In thousands) as of June 29, 2026; $3,815 (In thousands) as of December 29, 2025.
  • Accounts payable: 812,987 (In thousands) as of June 29, 2026; 543,538 (In thousands) as of December 29, 2025.
  • Contract liabilities: 186,770 (In thousands) as of June 29, 2026; 175,627 (In thousands) as of December 29, 2025.
  • Total current liabilities: 1,263,967 (In thousands) as of June 29, 2026; 962,197 (In thousands) as of December 29, 2025.
  • Long-term debt, net of discount and issuance costs: 969,456 (In thousands) as of June 29, 2026; 912,336 (In thousands) as of December 29, 2025.
  • Total long-term liabilities: 1,217,314 (In thousands) as of June 29, 2026; 1,115,881 (In thousands) as of December 29, 2025.
  • Total stockholders’ equity: 1,934,428 (In thousands) as of June 29, 2026; 1,762,253 (In thousands) as of December 29, 2025.
  • Total liabilities and stockholders’ equity: 4,415,709 (In thousands) as of June 29, 2026; 3,840,331 (In thousands) as of December 29, 2025.
  • Cash flow from operations was $96.4 million, or 9.6% of net sales.
  • TTM announced a $1.0 billion revolver and an upsized Term Loan B to increase balance sheet flexibility and provide additional capacity for organic and inorganic investments.

Analysis

TTM reported record quarterly net sales of $1.0 billion, up 37% year on year from $730.6 million. The release attributes the growth largely to continued AI demand in Data Center and Networking, which represented 40% of total net sales and increased 91% year on year. Medical, Industrial and Instrumentation grew 33% year on year, while Aerospace and Defense represented 37% of total net sales, grew 14% year on year, and recorded a healthy improvement in backlog. Total book to bill was 1.49 and total program backlog was over $1.7 billion.

Profitability improved alongside sales. GAAP gross margin was 21.1%, compared with 20.3% in the second quarter of 2025, while GAAP operating margin was 10.9%, compared with 8.5%. GAAP operating income was $109.1 million versus $61.8 million, and GAAP net income was $83.0 million, or $0.77 per diluted share, versus $41.5 million, or $0.40 per diluted share. Adjusted EBITDA was $166.8 million, or 16.6% of net sales, compared with $109.7 million, or 15.0% of net sales.

Non-GAAP profitability also reached a quarterly record. Non-GAAP net income was $106.9 million, or $0.99 per diluted share, compared with $60.8 million, or $0.58 per diluted share, in the prior-year quarter. Cash flow from operations was $96.4 million, or 9.6% of net sales. The quarter also included an unrealized loss on derivative instruments of 13,994 (In thousands) and a loss on extinguishment of debt of 747 (In thousands).

Balance-sheet resources included cash and cash equivalents of $507,905 (In thousands) and long-term debt, net of discount and issuance costs, of 969,456 (In thousands) as of June 29, 2026. Management cited a 0.9x net leverage ratio. The company announced a $1.0 billion revolver and an upsized Term Loan B, which it said provide flexibility and capacity for organic and inorganic investments. It expects its acquisitions of Swiss Technology Group AG and ILFA GmbH to close in the third quarter of 2026.

For the third quarter, TTM estimates net sales of $1.10 billion to $1.14 billion and non-GAAP net income of $1.21 to $1.27 per diluted share. For full-year 2026, it now expects approximately $4.4 billion of net sales and non-GAAP net income per share to approach $5.00. Both the third-quarter estimate and full-year outlook exclude contribution or impact from pending acquisitions.

Management, verbatim

We delivered another record high quarterly net sales and non-GAAP EPS, reflecting the strength of our strategic business model, positive market demand trends across end markets, and operational excellence from our employees. Revenues grew 37% year on year, powered largely by ongoing robust demand in the Data Center and Networking end market, which increased 91% year on year. Our Medical, Industrial and Instrumentation end market experienced 33% year on year revenue growth, and our Aerospace and Defense end market delivered 14% year on year revenue growth and a healthy improvement in backlog, reflecting our positive alignment with projected priority defense programs.

Edwin Roks, President & CEO of TTM Technologies, Inc.

Adjusted EBITDA margin was a healthy 16.6%, providing evidence that our margin expansion efforts are currently working. Cash from operations was $96.4 million and our net leverage ratio is 0.9x.

Edwin Roks, President & CEO of TTM Technologies, Inc.

Looking forward, we are excited about TTM’s strategic position given our strong existing customer momentum in addition to our announced agreements to acquire Swiss Technology Group AG and ILFA GmbH, as part of our entry into Europe, which we expect to close in the third quarter of 2026.

Edwin Roks, President & CEO of TTM Technologies, Inc.

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so comparison of actual results versus prior guidance is unavailable.
  • Prior-quarter comparisons for reported financial metrics were not provided.
  • Dollar revenue by Data Center and Networking end market was not provided.
  • Dollar revenue by Aerospace and Defense end market was not provided.
  • Revenue and percentage of total net sales for Medical, Industrial and Instrumentation were not provided.
  • Free cash flow was not provided.
  • Capital expenditures were not provided.
  • Share repurchases and dividends were not provided.
  • Third-quarter and full-year gross-margin, operating-expense, and tax-rate guidance were not provided.
  • The filing text provided is truncated following the beginning of an additional supplemental-data table; metrics contained only in the omitted portion cannot be captured.

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about TTMI earnings dates

When is TTM Technologies's next earnings date?
AlphAI has no confirmed date for TTMI yet. We publish an earnings date only once the company has set it, so this page shows one the day that happens.
Where does the date come from, and why is there no estimate?
A confirmed date comes from the company's own announcement. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so AlphAI shows nothing until the company confirms. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.